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ABSTRACT: Esophageal cancer is the 8th most common cancer 
in the world, with a survival rate of around 20% in five years. 
The most common histological type is squamous cell carcinoma, 
which presents geographical and ethnic variations. The risk factors 
for this pathology are not well defined. One of the main ones is 
infection by the Human Papilloma Virus (HPV), which presents 
frequent but transient conditions, which may regress spontane-
ously. The subtypes with the highest risk of malignancy are 16 
and 18. Thus, a systematic review of the literature was performed 
based on the reference data, such as Medline, The Cochrane Li-
brary, Embase and Lilacs. Articles in languages other than English, 
Portuguese and Spanish; articles where the full recovery was not 
possible; those that had missing or insufficient data for evalua-
tion the variables under study; those that focused on the pediatric 
population, animals and/or cell lines; presence of HPV in extra-
esophageal locations; benign lesions or malignant neoplasms other 
than squamous cell carcinoma (SCC); and case reports or case 
series were excluded. The study analyzed 64 abstracts of articles, 
25 of which were included in this review and 39 excluded. The 
study demonstrated the presence of HPV in the esophageal SCC 
in 648 (24.4%) of the 2647 neoplastic tissue samples, detected by 
different techniques. We observed, however, that this great preva-
lence is very related to the geographic region studied. Finally, it 
was considered that in fact there is a relationship between HPV 
and esophageal SCC, as analyzed in the vast majority of studies, 
but it is not yet possible to reach an effective conclusion about 
its interference in the patient’s prognosis.
Keywords: HPV infections; Human Papillomavirus infection; 
Esophagus cancer; Esophageal neoplasm; Prognostic
RESUMO: O câncer de esôfago é o 8º mais comum no mundo, 
com uma taxa de sobrevida em torno de 20% em cinco anos. 
O tipo histológico mais frequente é o carcinoma de células 
escamosas, o qual apresenta variações geográficas e étnicas. Os 
fatores de riscos para tal patologia não são bem definidos. Um 
dos principais é a infecção pelo Papiloma Vírus Humano (HPV), 
que apresenta quadros frequentes, porém transitórios, podendo 
regredir espontaneamente. Os subtipos que apresentam maior 
risco de malignidade são o 16 e 18. Dessa forma, uma revisão 
sistemática da literatura foi realizada a partir da base de dados 
de referência, como Medline, The Cochrane Library, Embase, 
Lilacs. Foram aplicados os critérios de exclusão e inclusão e 
assim obteve o resultado e assim 25 artigos incluídos nessa re-
visão e 39 excluídos. O estudo demonstrou presença do HPV no 
CEC de esôfago em 648 (24,4%) das 2647 amostras de tecidos 
neoplásicos, detectados através de diferentes técnicas. O que 
foi observado, todavia, é que essa grande prevalência muito se 
relaciona à região geográfica estudada. Por fim, foi considerado 
que de fato existe uma relação entre o HPV e o CEC de esôfago, 
como analisado na grande maioria dos estudos, porém ainda não 
se pode chegar a uma conclusão efetiva acerca da sua interferência 
no prognóstico do paciente.
Descritores: Infecção por HPV; Infecção por Papilomavírus 
Humano; Câncer de esôfago; Neoplasia de esôfago; Prognóstico.
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INTRODUCTION
Esophageal cancer is the eighth most common cause of cancer and the sixth most common 
cancer-related death1. In Brazil, excluding non-melanoma 
skin cancer, it is the sixth most incident among men and 
thirteenth among women2. Its prognosis is poor, with a 
survival rate of around 20% over five years. The most 
common histological type in the world is still squamous 
cell carcinoma, with geographical and ethnic variations, 
followed by adenocarcinoma1. The risk factors for the 
development of esophageal squamous cell carcinoma are 
not well defined, with the use of alcohol and tobacco ac-
countable as the main etiological factors. Infection with 
the human papilloma virus (HPV) has been reported as a 
risk factor for this neoplasm1. HPVs are viruses capable 
of infecting the skin or mucous membranes. The infection 
is very frequent but transient, spontaneously regressing 
most of the time. In the minority of cases, the infection 
may persist and develop precursor lesions which, if not 
identified and treated, can progress to cancer, especially 
in the cervix, but also in the vagina, vulva, anus, penis, 
oropharynx and mouth, and the subtypes 16 and 18 are 
responsible for 80% of the cases of malignancy1. 
OBJETIVE
The aim of the study is to perform a systematic 
review of the literature in order to establish the correlation 
between esophageal squamous cell carcinoma and HPV 
infection, as its risk factor   and to evaluate its prognosis 
in relation to lesions not linked to the virus.
MATERIALS AND METHODS
Ethical aspects
The present study was not submitted to the Ethics 
Council of the Institution involved because it is a systematic 
review, presenting only articles already published.
Search strategy, inclusion and exclusion criteria
Three authors searched the following electronic 
database: Medline, The Cochrane Library, Embase and Li-
lacs (Latin American and Caribbean Health Sciences). The 
search involved articles in Portuguese, English and Span-
ish, published until 2018, with a broad search strategy to 
avoid publication bias. The following keywords were used: 
“squamous-cell carcinoma”, “esophagus cancer”, “human 
papillomavirus”, “HPV”, “squamous cell carcinoma” and 
“esophageal cancer”.
Articles in languages other than those mentioned 
above were excluded, or those that concluded that full 
recovery was not possible. Those studies that did not 
contain data or insufficient data to evaluate the variables 
under study were also excluded. Articles that focused on 
the pediatric population, animals, cell lines, the presence 
of HPV in extra-esophageal locations, benign lesions or 
malignant neoplasms other than squamous cell carcinoma 
(SCC), case reports or case series were also excluded. 
Systematic review articles were used to discuss the results, 
not being used as part of these.
Data extraction
The data were extracted by two independent authors. 
For this, a data registration form was used for this purpose, 
including: type of study, country of origin, time of sample 
collection, number of patients with esophageal SCC, 
numbers of patients in the control groups, harmful habits 
(smoking and drinking), technology used in the study for 
the detection of HPV (polymerase chain reaction - PCR, 
in situ hybridization and/or immunohistochemistry - IHC), 
number of patients affected by HPV, identification of HPV 
type (HPV16 and/or HPV18) and 5-year survival.
Data analysis 
Initially, to facilitate the analysis, the articles were 
organized in the following groups: (1) oral or oropharyn-
geal HPV infection in patients with esophageal SCC; (2) 
Esophageal SCC and correlation with HPV; (3) Harmful 
habits and patients with esophageal SCC/HPV positive; 
(4) Overall 5-year survival of positive and negative HPV 
esophageal SCC patients.
We used the Microsoft Excel software (Microsoft 
Corp. (r), Redmond, WA) to tabulation of data and cal-
culations of the weighted average, frequency and 95% 
confidence interval (95% CI). The SPSS (r) version 17.0 
(SPSS (r) Inc.; Illinois, USA) software for regressions was 
used to assess the risk of HPV infection in each group, with 
calculation of odds ratios (OR) and 95% CIs. In all of these 
analyzes, the likelihood of occurrence of a α or type I error 
was considered to be less than 5% (p <0.05).
RESULTS
The study analyzed 64 abstracts of articles, ex-
cluding articles approaching only about HPV molecular 
biology; unrelated to the subject (28); benign neoplasms 
or only the HPV infection in the esophagus (15); studies 
that did not specify the type of malignant neoplasm or 
those including malignant neoplasms from other HPV-
associated topographies; making it impossible to calculate 
the variables in question (12) and systematic reviews (13); 
as shown in the flowchart in Figure 1. 
Based on these criteria, 25 articles were included 
in the review, with results obtained according to Tables 1, 
2, 3, and 4 and in Figures 2 and 3.
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Table 1. Demographic data of patients and sample of studies included in the review
Article Country Average age Men / Womens Smoking (n/HPV+) Alcohol (n/HPV+)
Cao 20144 China 60 (42-78) 84/21 63/14 52/15
Dreilich 20065 Suécia > 65 71/29 67/10 50/6
Fuhirata 19936 Japão 60-70 62/9 Ø ø
Kumar 20157 Índia >45 67/34 53/11
Souto-Damin 20168 Brasil 58,4 (45-85) 105/50 Ø ø
Wang 20159 China 49,9 (40-66) 147/3 144/27 147/26
Mehyar 201510 China ø ø Ø ø
Turkay 201611 Turquia >70 18/15 Ø ø
Soheli F 201612 Irã 62,63 70/33 Ø ø
Prokash 201713 Índia 60 (42-70) 9/9 10/5 5/2
Costa 201714 Brasil 60,9 (41-92) 100/23 99/10 97/10
Bahrnassy 200515 Egito 61,3 (40-72) 34/16 Ø ø
Zhang 201716 China 62 (44-76) 155/37 62/40 59/38
Geβner 201017 Malawi 60 27/13 Ø ø
Haeri 201318 Irã 59,6 (30-83) 16/14 Ø ø
Fahradi 200519 Irã 54 (25-75) 38/38 Ø ø
Antonsson 201020  Austrália 65,2 140/127 188/75 94/41
Guo 201221 China 51-60 712/488 519/ø 203/ø
Benamouzig 199222  França ø ø Ø ø
Talamini 200023 Itália >57 41/4 36/29 41/29
Haohua  201424 China 63 144/33 Ø ø
Hayedeh  201325 Irã 62 (41-82) 14/16 Ø ø
Herbster  201226 Brasil 60,31 184/52 211/24 199/18
Andrzej  201227 Polônia 59 49/7 Ø ø
Herrera-Goepfert 200928  México 61 (27-85) 47/13 28/6 36/9
ø : data not available in the article
Figure 1: Flowchart of articles
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Table 2. Prevalence of HPV in esophageal squamous of cells carcinoma samples from studies included in the review
Article Study time (Years) N (CEC) HPV positive cases / (%)
Cao 20144 02 105 29 (27,6)
Dreilichi 20065 10 100 16 (16)
Fuhirata  19936 11 71 24(33,8)
Kumar  20157 04 101 22 (22)
Souto-Damin 20068 07 165 26 (15,7)
Wang 20159 03 150 27 (18)
Mehyar 201510 02 198 158 (79,7)
Turkay 201611 13 33 3 (9,09)
Soheili F 201612 06 103 11 (10,7)
Prakash 201713 01 18 09 (50)
Costa 201714 01 87 12(13,8)
Bahrnassy 200515 02 50 27 (54)
Zhang 201716 03 192 67 (34,9)
Geβner 201017 / 40 6 (15)
Haeri 2013 18 02 130 0 (0)
Fahradi 200519 05 38 14 (36,8)
Antonsson 201020 03 222 8 (3,5)
Guo 201221 01 300 99 (33)
Benamouzig 199222 / 12 5 (41,6)
Talamini 200023 08 45 2 (4,4)
Haohua  201424 12 177 6 (3,3)
Hayedeh  201325 02 30 0 (0)
Herbster  201226 09 264 34 (13)
Andrzej  201227 03 56 28 (50)
Herrera-Goepfert 200928 08 60 15 (25)
Total 2647 648 (24,4; IC95 16,6 - 32,3)
Table 3. 5-year survival of patients with esophageal SCC ac-
cording to studies included in the review.
Article 5 year survival (HPV +/- %)
Cao 20144 65,5 / 43,4
Dreilich 20065 11,0 / 11,0 
Fuhirata 19936 9,2 / 22,8
Kumar 20157 72,2 / 49,3
Antonsson 201020 75 / 36
Herbster 201226 0 / 0
Wang 20159 48 / 21
5 years survival HPV+ 35,9% (IC95: 19,9 - 51,9)
HPV- 21,9% (IC95: 8,7 - 35,1)
Table 4. HPV as a risk factor of esophageal SCC in the studies 
included in the review
Article HPV + HPV - SCC Control
Geβner 201017 7 47 40 15
Haeri 201318 0 0 30 30
Fahradi 200519 19 59 40 38
Antonsson 201020 8 269 222 55
Guo 201221 154 1046 300 900
Benamouzig 199222 6 17 15 8
Andrzej  201223 32 59 56 35
Total (p≤0,05) 226 1558 702 1081
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Figure 2. Articles according to the countries of publication.
Figure 3. Forest-plot OR.
DISCUSSION
Esophageal carcinoma can already appear as a 
frankly malignant lesion or appear as a progression of 
premalignant lesions. The tumor begins in the internal lining 
layer of the organ (mucosa), penetrating the submucosa, 
muscular layer and adventitia, and may infiltrate adjacent 
organs, such as the trachea or the aorta.
Its etiology is associated with the histological type 
of the disease, and the squamous cell carcinoma is still 
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the most common and strongly related to smoking and 
alcohol consumption, and adenocarcinoma, associated 
with Barrett’s esophagus and obesity. Among other 
factors described, consumption of food and water rich 
in nitrates and nitrosamines, low intake of fruits and 
vegetables, mycotoxins, consumption of high temperature 
drinks, palmoplantar tylosis, Plummer-Vinson syndrome, 
achalasia, caustic strictures and genetic factors are also 
related to this type of cancer.
HPV has been implicated as a risk factor for esopha-
geal squamous cell carcinoma since 1982, by the study by 
Syrjaren et al.29, describing the progression of the lesion 
from flat condyloma to invasive carcinoma. Among the 
100 types of HPV, the 16 and 18 are those with the high-
est rates of oncogenic predisposition. They are attracted 
to squamous epithelial cells on wet surfaces, including the 
mucosa of the genital and aerodigestive tracts, in addition 
to the skin, and can remain throughout their life cycle, 
including replication28.
The study by Patham et al.30 in 2017 analyzed the 
presence of esophageal papilloma and HPV through PCR 
in patients undergoing upper digestive endoscopy in 13 
years, with 60 cases of papilloma found in this period, 
and of these, 19 paraffinized tissues remaining from in-
cisional biopsy of the lesion performed in the procedure 
underwent DNA virus research 9 had positive PCR for 
HPV 16. (47.4%)27.
Our study showed the presence of HPV in the 
esophageal SCC in 648 (24.4%) of the 2647 samples (Table 
2) of neoplastic tissues, detected using different techniques. 
This prevalence varies widely according to location, with 
higher incidences presented in Chinese studies, in which 
the prevalence of the virus in cases of esophageal SCC was 
around 35%. The meta-analysis by Ludmir et al.31, showed 
the same geographical difference, especially when the 
patients involved were from Asia, in which the percentage 
of HPV in the esophageal SCC reached 38%, in contrast to 
studies involving patients from South America, in which 
the study with the highest prevalence was 16.6%21. The 
systematic review performed by Zhang et al.32 in 2014, 
analyzed 26 studies with a total of 3026 patients with 
esophageal SCC from all regions of China, assessing the 
presence of HPV 16 in neoplastic tissues. A prevalence of 
39.7% was demonstrated, with a greater predominance in 
the southern region of the country, which had a prevalence 
of 47.8%, despite presenting the lowest number of cases 
studied than in other regions21.
The 2015 meta-analysis by Guo et al.33, also per-
formed in China, researched the presence HPV 18 in pa-
tients with esophageal SCC, involving 2556 patients, show-
ing that this subtype was present in 4.1% of the lesions33.
In contrast, the 2013 systematic review by Li et 
al.34, analyzed the remaining histological analysis of 8990 
cases of esophageal SCC, which underwent PCR, with 
prevalence of 22.2% of virus DNA, with a predominance 
of HPV 1634. The importance of high prevalence of HPV 
infection in China is found in the country’s large popula-
tion, associated with the flow of emigration and transit of 
its citizens around the world after its economic expansion.
The articles evaluated in our study suggest a strong 
association between HPV and esophageal malignancy in 
question, in view of the prevalence of the virus in the studies 
and the OR calculated from 7 present case-control articles 
was 3.93 (CI: 95, 3.83-4.02). It must be remembered that, 
as shown in table 1, patients infected with HPV also have 
a history of smoking and drinking habits, which can be 
a confusing factor for establishes it as a risk factor. The 
systematic review by Li et al.34 had as a result of its OR 
3.32 (CI: 95, 2.26–4.87) in 17 evaluated articles.34 The 
2013 Syrjänen29 meta-analysis, involving 39 studies to 
verify the difference between the virus detection methods, 
demonstrated that the presence of the virus cannot really 
be associated with the etiology of lesion29.
The meta-analysis by Guo et al.35, 2016, involved 
1184 cases of esophageal SCC, analyzing the risk of death 
in positive and negative HPV patients, demonstrating that 
the presence of the virus (0.73 relative risk, CI:95, 0.44-
1.21) has no interference in the prognosis of the neoplasia35. 
The articles in which the overall 5-year survival analysis 
(Table 3) was present, there was no difference between 
patients infected by the virus and those not infected.
CONCLUSION
The studies evaluated by systematic review and 
meta-analysis show that there is an association between 
HPV and esophageal cancer, especially in certain geo-
graphic areas, without having greater influences on the 
patient’s prognosis. More studies, essentially prospective 
cohort studies should be performed to detail its role in the 
oncogenesis of esophageal SCC and thus, establish it defini-
tively as a risk factor and thus, build prevention strategies.
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